ICU Medical price target raised to $158 from $135 at Raymond James

Raymond James raised the firm’s price target on ICU Medical to $158 from $135 and keeps an Outperform rating on the shares. ICU Medical reported “exceptional” Q2 results, beating on every key metric, the analyst tells investors in a research note. The firm is not modeling this level of growth going forward, but says the business is clearly gaining momentum and the raised guidance should prove conservative.